Veritas Asset Management’s BeOne Medicines Ltd ONC Stock Holding History

Veritas Asset Management’s Portfolio ONC Stock Details ONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-4,000	Closed	-$754K	–	34
2020 Q2	$754K	Hold	4,000	–	–	0.01%	29
2020 Q1	$492K	Buy	+4,000	New	+$626K	﹤0.01%	31
2019 Q4	–	Sell	-6,000	Closed	-$735K	–	27
2019 Q3	$735K	Hold	6,000	–	–	0.01%	25
2019 Q2	$744K	Hold	6,000	–	–	0.01%	24
2019 Q1	$792K	Buy	+6,000	New	+$810K	0.01%	23
2018 Q3	–	Sell	-22,000	Closed	-$3.38M	–	30
2018 Q2	$3.38M	Buy	+22,000	New	+$3.92M	0.03%	28

Other funds holding ONC

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Veritas Asset Management's ONC Position: Q3 2020 in Review

Veritas Asset Management sold out of BeOne Medicines Ltd (ONC) in Q3 2020, closing a stake of 4,000 shares — an estimated $754K sold.

Veritas Asset Management first reported a position in ONC in Q2 2018 and held it in 6 quarters. The position peaked at $3.38M in Q2 2018. 244 funds tracked by Wall St. Rank hold ONC as of Q3 2020.

Veritas Asset Management reported no remaining BeOne Medicines Ltd position as of Q3 2020 after selling out during the quarter.
Veritas Asset Management sold 4,000 BeOne Medicines Ltd shares in Q3 2020, an estimated $754K.
Veritas Asset Management first reported a position in BeOne Medicines Ltd in Q2 2018 and held it in 6 quarters.
Veritas Asset Management's BeOne Medicines Ltd position peaked at $3.38M in Q2 2018.
244 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q3 2020.

Based on Veritas Asset Management's 13F filing for Q3 2020, filed 12 Nov 2020.